Oncology

Top news of the day from across the health care landscape.

Chinese plant Huang-Qin compound shows promise treating cancer and liver disease.

CTLA-4 molecule on T cells offer potential therapeutic target.

Treatment costs climb with advanced-stage breast cancer compared with earlier stages.

Methotrexate and decadron could lower relapse rates of patients with acute lymphoblastic leukemia.

Faulty protein kinases can lead to conditions such as diabetes, cancer, and cardiovascular disease.

Breakthrough Therapy Designation nivolumab (Opdivo) granted for previously treated recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) after platinum based therapy.

Cabometyx targets multiple tyrosine kinases involved in the development of renal cell carcinoma.

Neratinib plus paclitaxel did not improve outcomes in metastatic ERBB2-positive breast cancer.

Mevalonate pathway associated with cell-signaling protein that promotes breast cancer development.

In some cases, Raynaud's Disease can cause blood circulation to fingers and toes to permanently diminish, leading to deformities.

Study finds 12 total drug classes that can cause Raynaud’s disease.

Blue-green algae discovered in Panama carries potent anti-cancer activity.

Recent advances and updates in oncology and cancer drug development.

Gastrointestinal stromal tumors result in higher mortality than originally estimated.

TZD-based medicines effectively improve glucose uptake.

Advanced T cell receptor sequencing may predict efficacy of immunotherapy in brain cancer treatment.

Top news of the day from across the health care landscape.

Study finds fewer exchange health plans are placing specialty drugs on the highest tier.

Top news from across the health care landscape.

Pfizer announced Ibrance met its primary endpoint in postmenopausal women with human epidermal growth factor receptor 2-negative (ER+, HER2-) advanced or metastatic breast cancer.

Pfizer announced Ibrance met its primary endpoint in postmenopausal women with human epidermal growth factor receptor 2-negative (ER+, HER2-) advanced or metastatic breast cancer.

RO 48-8971 may inhibit the growth of and kill prostate cancer cells.

Bisphenol A is found in numerous plastic and resin household products.

Blocking the recruitment of blood vessels suppresses small cell lung cancer tumor growth.

Consuming 2.5 servings of coffee per day found to decrease colorectal cancer development by up to 50%.

Top news of the day from across the health care landscape.

Afatinib (Gilotrif) shows significant improvements in overall survival and disease progression.